129S6/SvEv- Liastm1Mae /J

129S6/SvEv- Liastm1Mae /J

Cat. No.: DMM-001288

Status Age Sex
  • Live Mouse
  • Frozen Embryo
  • 4 weeks
  • 12 weeks
  • Customized Age
  • Male
  • Female
Model Overview
Model Description This Liastm1Mae mutant allele has the exons 4-6 of the of the lipoic acid synthetase (Lias) gene deleted. The deleted region encodes the functionally conserved Cys motifs of the enzyme responsible for converting octanoic acid to α-lipoic acid (also called 1,2-dithiolane-3-pentanoic acid, thioctic acid, ALA, or LA). These Lias mutant mice may be useful in studying α-lipoic acid requirements during development, mitochondrial dysfunction, and oxidative stress-related diseases such as diabetes, atherosclerosis, and neurodegenerative disorders.
Strain Name 129S6/SvEv-Liastm1Mae/J
Background Strain 129S6 / SvEv
SPF Yes
Research Application Diabetes
Target Information
Target Name LIAS
Synonyms 2900022L22Rik, 4933425M12Rik, 7a5ex, HGCLAS, HUSSY-01, LAS, LIP1, LS, MGC7254, mLip1, PDHLD
Gene ID 11019
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Related Models
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top